Literature DB >> 19575068

Skin manifestations of systemic disease.

Adriene Lee1.   

Abstract

BACKGROUND: Dermatologic complaints are a common reason for presentation to a general practitioner. In some cases, one needs to determine if the complaint may be a manifestation of a more serious underlying systemic disease.
OBJECTIVE: This article aims to highlight common dermatologic presentations where further assessment is needed to exclude an underlying systemic disease, to discuss classic cutaneous features of specific systemic diseases, and to outline rare cutaneous paraneoplastic syndromes. DISCUSSION: Skin manifestations of systemic disease are wide, varied, specific and nonspecific. Generalised pruritus and cutaneous vasculitis are more common cutaneous presentations where an underlying systemic disease may be present and will influence management. In certain chronic diseases such as connective tissue disease and chronic liver disease, there are characteristic cutaneous findings. Internal malignancies such as multiple myeloma may present with distinctive cutaneous findings, which need to be recognised to institute a search for the underlying neoplasm. The skin has the potential to provide a window into the patient and aid in the diagnosis of diseases of all organ systems.

Entities:  

Mesh:

Year:  2009        PMID: 19575068

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers.

Authors:  Giovanni Ponti; Gabriele Luppi; Lorena Losi; Alberto Giannetti; Stefania Seidenari
Journal:  J Hematol Oncol       Date:  2010-01-11       Impact factor: 17.388

Review 2.  Paraneoplastic cutaneous manifestations: concepts and updates.

Authors:  Josenilson Antônio da Silva; Kleyton de Carvalho Mesquita; Ana Carolina de Souza Machado Igreja; Isabella Cristina Rodrigues Naves Lucas; Aline Ferreira Freitas; Sandra Maximiano de Oliveira; Izelda Maria Carvalho Costa; Iphis Tenfuss Campbell
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.